Member Info for technick

StoneChecker is used upfront of any treatment including this method of treatment so it looks to be very complementary...

Nice to see some strong buying and a blue day, we should see this get back to the las t placing price swiftly, that was done on a discount to the prevailing share price so all things being equal it should pass that into double figures when news comes in...

Thank you, that would make sense as the share price is stuck. As you've said before, a little more visibility and trading and this will recover quickly

£10.5k on the 23rd and £10k today, these are chunky buys for Genedrive, not your normal trades, thoughts anyone? Or am I being too optimistic that something is brewing... Certainly there seemed to be a flurry of buying on the 22nd and 23rd

some interesting trading again today, but no tick up on share price despite the larger than usual trades

share trade of 10 shares, is that someone buying in or selling out ;)

IQAI use TexRad in their product. It's a tool that allows images to be interpreted by the IQAI software and is only part of the software, the analysis and AI is additive and owned by IQAI. Under normal circumstances companies that license technology have a continuity of supply clause which protects them in the even that the licensee goes under. If Feedback fold I should imagine these protections are in place and the company will continue to be able to use the tool. I don't think IQAI would merge with Feedback, a bit like saying Apple should have merged with ARM, it's only a part of the system albeit an important one. IMO.

So far there is little information on the sales values. However, according to a recent interview the sales potential was stated to be around $100k per installation and had become a subscription based rather than single sale based sales cycle. It wasn't clear if this was a bundle or suite of applications or if it just referred to StoneChecker on its own - does anyone have a view? It does show that quite quickly the Company has the potential to have quite large sales values. For a balanced view, if the Company doesn't sell product then they don't have the potential. My money (quite literally) is that they do sell product and that they do realise commercial sales!

I'll just be sure to state the obvious counter position in my posts, good news up, bad news down. we are as investors expecting good news, otherwise we would have sold our position. I'm not expecting bad news here, the BOD are doing a great job and even when there is an opportunity to do a raise, they are being proportionate and being respectful to the shareholders. IMO. I bought about a year ago on the basis that there are few investment opportunities in the medical AI arena. I am very happy with my investment.

My post wasn't meant to be a ramp, the last raise was at 9p, the share price had reached over 15p prior to that after news from the FDA arrived. We are at 6p today. On commercial news the share price should recover to somewhere above the last raise of 9p and possibly back to the 15p mark. For balance, if no commercial news arrives or if the commercial news is negative, then the share price will drop. Seems a fair description of where we are. The company has an innovative product with FDA arrival for sale. It's last raise was done on this basis to investors that are not PI's. By definition a month after that raise it is fair to say in such a short period with no news to contradict that value, that it is oversold. IMO.

Traders known this was over sold, last raise at 9p and over 15p paid before that. I suspect this will easily be back to 15p on confirmation of commercial contracts

Nice summary, thank you. It will be interesting to see what sales the hearing loss test can support once the NHS completes it's studies. With a 1/500 probability and an estimated 180 babies saved from hearing loss each year if the test was deployed, that would be 90,000 tests per year. Thats the UK alone. Anyone have any views?

maybe blueberg buying back in, lol

some chunky sized trades this morning, something brewing?

Great to see some positive news, time for this to recover now. More publicity will lead to more sales of this highly innovative product. Yes the market is a mature one, but this represents a new wave of innovation in the market...

It's a ridiculous spread and does nothing to support the shareholders who support this business and who have invested here. Agree, once there is more volume this will shoot up quickly and now we have a timetable of sorts of expected news. My guess (opinion) is we will see a trade buyer appear at the same time as the news comes in.

good publication here and the potential for POC tests such as Genedrive in the eradication of drug induced hearing loss, not sure if it's been posted. https://journals.sagepub.com/doi/full/10.1177/2331216519878983, it seems like Genedrive is the first deployment of such a test at POC and therefore allows testing on admission. Plenty of other similar pharmacogenetic tests that could be deployed on this platform I think

Why drop the bid but then trade at what would have been a buy before dropping the bid and then not even up the bid to what it was? Should this not have ticked up today?

No news is good news. Partner negotiations and particularly ones that are not simple distribution agreements, take time to negotiate. All good in my opinion. I suspect a large multinational equipment supplier will be all over this. Time will tell but I certainly am holding. Strong BOD, good history in building high value for shareholders, what this space!

Really nice report on where the business is and the opportunity, significantly undervalued in my opinion and hopefully others will start to see the potential here